about
Understanding and predicting suicidality using a combined genomic and clinical risk assessment approachPrecision medicine for suicidality: from universality to subtypes and personalization.Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment.The relationship between cognitive insight and quality of life in schizophrenia spectrum disorders: Symptom severity as potential moderator.Psychological Distress and Rates of Health Insurance Coverage and Use and Affordability of Mental Health Services, 2013-2014.Consumer factors predicting level of treatment response to illness management and recovery.Aspects of Theory of Mind that attenuate the relationship between persecutory delusions and social functioning in schizophrenia spectrum disorders.An examination of perceptions of individuals with an intellectual disability, with and without co-morbid schizophrenia: effects of labels on stigma.Fentanyl related overdose in Indianapolis: Estimating trends using multilevel Bayesian models.Effects of Risk-Based Firearm Seizure Laws in Connecticut and Indiana on Suicide Rates, 1981–2015Firearm Legislation and Fatal Police Shootings in the United StatesValidity of a two-item screen for early psychosisThe impact of age on the validity of psychosis-risk screening in a sample of help-seeking youthEMS naloxone administration as non-fatal opioid overdose surveillance: 6-year outcomes in Marion County, IndianaUsing the K-SADS psychosis screen to identify people with early psychosis or psychosis risk syndromesTowards precision medicine for stress disorders: diagnostic biomarkers and targeted drugsPublic understanding of different kinds of voice-hearing experiences: Causal beliefs, perceptions of mental illness, and stigmaPredictors of attendance in health and wellness treatment groups for people with serious mental illness
P50
Q36594563-B94DAD52-DAC1-4A53-874C-BCC4D12909FBQ38624049-F9A440B1-1977-4FC2-99C2-1D0C987FCB10Q38885573-F1936E7C-B922-4FE8-AD2B-C2F8153F70ACQ38939482-F0F8F8C8-7994-48A8-BD49-33C5FE073367Q39100974-8EA7F3E4-8EB1-461F-B637-C4ACFFD8E183Q47569051-CBEDE15E-8CF6-437D-9C25-2A8DB5CE8E02Q47979314-72C7067F-5D81-4CC3-A904-CA1D96B8C02EQ53400696-4A25F7DF-9523-4BF0-9BD2-8D23AD5544C3Q53414866-5086ED4D-EC5C-437D-9E1E-6694F81D502CQ57257034-710C2F15-6F85-483F-9128-43B03DC770C1Q58121400-14E408F0-A929-4E5E-8836-1185562B2BD6Q90511099-E07EE318-EB4D-4053-B823-8D638628BB27Q91705183-7573C7CC-F07C-427A-BDCA-3A91B81C33EBQ91749267-263ECFDF-1350-4180-B429-B5C1AE7751C1Q92063851-AFD1DE0E-F8A8-4B40-8F8C-5326C15E0C1CQ92311535-10BCD0A8-E098-4BF2-8FA4-CC88EB9F3247Q92842515-3A72C5FA-51A4-4662-8107-45B3FD4F2608Q93155069-105E955F-B3DC-49BE-A27F-FA9F56A49306
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Peter Phalen
@ast
Peter Phalen
@en
Peter Phalen
@es
Peter Phalen
@nl
Peter Phalen
@sl
type
label
Peter Phalen
@ast
Peter Phalen
@en
Peter Phalen
@es
Peter Phalen
@nl
Peter Phalen
@sl
prefLabel
Peter Phalen
@ast
Peter Phalen
@en
Peter Phalen
@es
Peter Phalen
@nl
Peter Phalen
@sl
P106
P1153
56784308500
P21
P31
P496
0000-0002-4219-3475